Accessibility Menu
 
SomnoMed logo

SomnoMed

(ASX) SOM

Current Price$0.57
Market Cap$122.69M
Since IPO (2004)-81%
5 Year-71%
1 Year+24%
1 Month-14%

SomnoMed Financials at a Glance

Market Cap

$122.69M

Revenue (TTM)

$218.75M

Net Income (TTM)

$8.56M

EPS (TTM)

$-0.01

P/E Ratio

-47.06

Dividend

$0.00

Beta (Volatility)

0.10 (Low)

Price

$0.57

Volume

36,650

Open

$0.57

Previous Close

$0.57

Daily Range

$0.56 - $0.57

52-Week Range

$0.44 - $0.94

SOM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SomnoMed

Industry

Healthcare Equipment and Supplies

CEO

Amrita Blickstead, MBA; Karen Borg

Headquarters

Crows Nest, NSW 2065, AU

SOM Financials

Key Financial Metrics (TTM)

Gross Margin

57%

Operating Margin

2%

Net Income Margin

-2%

Return on Equity

-5%

Return on Capital

5%

Return on Assets

-3%

Earnings Yield

-2.12%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$122.69M

Shares Outstanding

219.08M

Volume

36.65K

Avg. Volume

45.95K

Financials (TTM)

Gross Profit

$66.73M

Operating Income

$3.62M

EBITDA

$1.58M

Operating Cash Flow

$7.78M

Capital Expenditure

$2.42M

Free Cash Flow

$5.36M

Cash & ST Invst.

$17.29M

Total Debt

$8.03M

SomnoMed Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$60.72M

+34.6%

Gross Profit

$34.39M

+39.6%

Gross Margin

56.64%

N/A

Market Cap

$122.69M

N/A

Market Cap/Employee

$408.95K

N/A

Employees

300

N/A

Net Income

$792.00K

+112.5%

EBITDA

$5.66M

+592.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$4.02M

+148.8%

Accounts Receivable

$18.15M

+44.5%

Inventory

$7.60M

+57.4%

Long Term Debt

$7.77M

-50.4%

Short Term Debt

$6.24M

+15.7%

Return on Assets

-3.20%

N/A

Return on Invested Capital

5.06%

N/A

Free Cash Flow

$1.77M

+126.1%

Operating Cash Flow

$4.15M

+190.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AHC.AXAustco Healthcare Limited
$0.34+1.52%
NYR.AXNyrada Inc.
$0.58+9.43%
LDX.AXLumos Diagnostics Holdings Limited
$0.17+3.03%
ONE.AXOneview Healthcare PLC
$0.16-5.88%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$16.10+0.04%
AAPLApple
$271.35+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.63+0.10%
MARAMara Holdings
$11.99+0.12%

Questions About SOM

What is the current price of SomnoMed?

SomnoMed is trading at A$0.57 per share.

What is the 52-week range for SomnoMed?

Over the past 52 weeks, SomnoMed has traded between A$0.44 and A$0.95.

How much debt does SomnoMed have?

As of the most recent reporting period, SomnoMed reported total debt of $8.03M.

How much cash does SomnoMed have on hand?

SomnoMed reported $17.29M in cash and cash equivalents in its most recent financial results.

What is SomnoMed’s dividend yield?

SomnoMed does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.